Free Trial
NASDAQ:CELZ

Creative Medical Technology (CELZ) Stock Price, News & Analysis

Creative Medical Technology logo
$2.00 +0.04 (+2.09%)
As of 03:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Creative Medical Technology Stock (NASDAQ:CELZ)

Key Stats

Today's Range
$1.93
$2.04
50-Day Range
$1.80
$3.03
52-Week Range
$1.69
$6.90
Volume
18,965 shs
Average Volume
50,000 shs
Market Capitalization
$5.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Receive CELZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter.

CELZ Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Headlines

CELZ Stock Analysis - Frequently Asked Questions

Creative Medical Technology's stock was trading at $2.31 at the start of the year. Since then, CELZ shares have decreased by 13.4% and is now trading at $2.0010.
View the best growth stocks for 2025 here
.

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) released its earnings results on Friday, May, 9th. The company reported ($0.83) earnings per share for the quarter, missing the consensus estimate of ($0.52) by $0.31. The firm had revenue of $0 million for the quarter.

Creative Medical Technology shares reverse split on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional investors of Creative Medical Technology include Armistice Capital LLC (3.38%). Insiders that own company stock include Timothy Warbington and Michael H Finger.
View institutional ownership trends
.

Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creative Medical Technology investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), FuelCell Energy (FCEL), Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL) and ChargePoint (CHPT).

Company Calendar

Last Earnings
5/09/2025
Today
5/23/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CELZ
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,290,000.00
Pretax Margin
-48,354.54%

Debt

Sales & Book Value

Annual Sales
$14,000.00
Price / Cash Flow
N/A
Book Value
$7.48 per share
Price / Book
0.27

Miscellaneous

Free Float
1,699,000
Market Cap
$5.17 million
Optionable
Not Optionable
Beta
2.00
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:CELZ) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners